This paper will address specifically the 24th edition of the São Paulo Biennial (1998), which took up Oswald de Andrade’s concept of anthropophagy as a guiding axis, but it will also bring to light the first edition of the Mercosul Biennial, which was held in 1997 in the city of Porto Alegre, situated in the south of Brazil, with the int
Narratives of childless widows: exploring the lived experiences and well-being of childless widows in rural Nigeria
Background: Widows are socioeconomically disadvantaged, especially in low resource regions.Childless widows are a group whose plight may be worse given sociocultural circumstances.In the current study, we examined the lived experiences of childless widows living in remote Nigeria, highlighting this group as being in critical need for social interve
Evaluating the impact of a new educational tool on understanding of polygenic risk scores for alcohol use disorder
IntroductionAs gene identification efforts have advanced in psychiatry, so have aspirations to use genome-wide polygenic information for prevention and intervention.Although polygenic risk scores (PRS) for substance use and psychiatric outcomes are not yet available in clinical settings, individuals can access their PRS through online direct-to-con
Magnesium and type 2 diabetes mellitus: Clinical and molecular mechanisms
Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases, affecting hundreds of millions Pregnancy of people worldwide.Environmental factors influence the progressive development of diabetes, the main ones being obesity, hypertension, dyslipidemia, and genetic factors.In addition to the above factors, magnesium (Mg2+) deficiency h
An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo
Urokinase plasminogen activator receptor (uPAR) is a multidomain protein that plays important roles in the growth, invasion, and metastasis of a number of cancers.In the present study, we examined the effects of administration of a monoclonal anti-uPAR antibody (ATN-658) on prostate cancer progression in vitro and in vivo.We examined the effect of